Add a Comment

In response to:

Zoledronic acid, a once-yearly infusion, has been approved by Health Canada for treatment of postmenopausal osteoporosis. Known as Reclast in the U.S., the bisphosphonate medication received FDA approval for that purpose just a few months ago. It ...

Subject:

Comment:

Note: This is publicly visible on this site and the rest of the internet. Do not include personally identifiable information in your comment.

I am a registered user

Display Name:		Note: This Display Name is not required. Please remember that this Display Name will be publicly visible on this site and the rest of the Internet. To maintain your anonymity do not use your name, email address, or other personally identifiable information in your Display Name.
Email:		Your email helps us get in touch if necessary. Your e-mail address will not be posted on our site and will be kept confidential as provided in our Privacy Policy.

Type the letters shown in the box to the right:

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on OsteoporosisConnection.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.


Email:
Password:
Remember Me:

Sign in

OsteoporosisConnection.com

Add a Comment